Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 6,068 $ 15,199
Accounts receivable, net 9,483 3,437
Other current assets 2,170 1,172
Total current assets 17,721 19,808
Property and equipment, net 837 654
Other intangible assets, net 29,853 33,105
Other long-term assets 31 31
Total assets 48,442 53,598
Current liabilities:    
Accounts payable 1,059 391
Accrued salary and bonus 1,424 1,394
Other accrued expenses 5,091 5,004
Current liabilities from discontinued operations 918 1,302
Total current liabilities 8,492 8,091
Contingent consideration 2,693 1,349
Other long-term liabilities 4,319 4,289
Total liabilities 15,504 13,729
Commitments and contingencies (Note 10)
Stockholders' equity:    
Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding
Common stock, $.01 par value; 100,000,000 shares authorized; 28,767,344 and 27,900,806 shares issued, respectively; 28,694,275 and 27,836,456 shares outstanding, respectively 287 278
Additional paid-in capital 175,820 173,062
Accumulated deficit (141,489) (131,800)
Treasury stock, at cost (73,069 and 64,350 shares, respectively) (1,680) (1,671)
Total stockholders' equity 32,938 39,869
Total liabilities and stockholders' equity $ 48,442 $ 53,598